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Objective: Differentiation of bronchioloalveolar carcinoma from other subtypes of
lung adenocarcinomas is important in the preoperative assessment of patients. We
examined the biologic aggressiveness of small-sized adenocarcinomas according to
the pathologically defined bronchioloalveolar carcinoma degree and its correlation
with computed tomography findings. In addition, we attempted to predict which
patients were suitable for a lesser resection.
Methods: Of 424 consecutive patients who underwent operation for primary lung
cancer in the last 3 years, 114 with a histopathologically proven adenocarcinoma 3
cm or less in diameter underwent complete removal of the primary tumor. We
examined the characteristics of patients classified into 3 groups based on the
proportion of the bronchioloalveolar carcinoma component: 0% to 20% (n  40),
21% to 50% (n  38), and 51% to 100% (n  36). We also investigated the
correlation of the bronchioloalveolar carcinoma component with computed tomog-
raphy findings such as ground-glass opacity (defined as a hazy increase on the lung
window) and tumor shadow disappearance rate (defined as the ratio of the tumor
area of the mediastinal window to that of the lung window).
Results: Male gender (P .0001), advanced pathologic stage (P .001), larger size
of the tumor (P .004), nodal involvement (P .04), pleural invasion (P .0003),
lymphatic invasion (P  .002), and vascular invasion (P  .0002) were observed
more often among patients with a smaller proportion of bronchioloalveolar carci-
noma. A positive and significant correlation was found between the rate of bron-
chioloalveolar carcinoma component and ground-glass opacity (R2  0.488, P 
.0001) and tumor shadow disappearance rate (R2  0.727, P  .0001). As an
independent predictor of nodal status, tumor shadow disappearance rate (P  .015)
and bronchioloalveolar carcinoma component (P  .015), as well as tumor size,
were significantly valuable, although ground-glass opacity proportion (P  .086)
was marginally informative.
Conclusions: Small-sized adenocarcinomas with a greater ratio of bronchioloalveo-
lar carcinoma component showed less aggressive behavior. Both tumor shadow
disappearance rate and ground-glass opacity ratios, which are obtained preopera-
tively, were well associated with bronchioloalveolar carcinoma ratios, which are
determined postoperatively. Furthermore, tumor shadow disappearance rate had a
stronger impact as a predictor of bronchioloalveolar carcinoma component. Preop-
erative assessment of tumor shadow disappearance rate may be useful to identify
patients requiring a less extensive pulmonary resection.
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The extensive use of computed tomography(CT) scanning for early detection of lungcancer is confronting our approach to sur-gery. However, there are no definite criteriaregarding CT findings that characterize earlylung cancers or determine the clinical and
tumor biology preoperatively. The increasing number of
patients with small-sized lung cancers has led to doubts
about whether some of these cancers can be treated with a
lesser resection, despite much controversy surrounding the
effectiveness of lesser resection as an alternative to lobec-
tomy.1-6 Approximately one fifth of clinical T1 cancers are
linked to nodal involvement,1,5,7 and the rest have a more
inactive biologic performance that should be defined as
early cancers. The risks of nodal involvement and subse-
quent systemic metastases are not completely associated
with the size of the tumor. The capacity to differentiate
which of these small cancers would have an active or
inactive biologic performance is remarkably crucial. Diag-
nosis of lung cancers at an early stage is important because
eradication of small-sized tumors can be accomplished with
less loss of tissue. This results in reduced operative com-
plications and loss of pulmonary function. In addition, the
procedure is associated with longer survival, and if another
tumor is found, the patient would be in better condition to
resist a second resection of tissues. The larger the extent of
the initial resection, the more restricted the surgical choice
for potential subsequent resections.
Ground-glass opacity (GGO), termed as a misty and
obscure component in lung attenuation on high-resolution
CT (HRCT), seems linked to tumor biology and thereby to
the risk of nodal involvement. In particular, cancers 2 cm or
smaller, in which the ratio of GGO relative to the whole
shadow of the tumor is 50% or greater, are bronchioloal-
veolar carcinomas (BACs) without nodal involvement.8-10
In addition, BAC may stand for the preinvasive type of
adenocarcinoma often seen at the margin of invasive ade-
nocarcinoma.1-14 From these findings, we speculated that
limited lung resection might be an acceptable approach to
the treatment of small BACs. In addition, Takamochi and
colleagues15 proposed a radiologic parameter, namely, the
tumor shadow disappearance rate (TDR), designed from
tumor shadows on both pulmonary and mediastinal window
setting images on CT, as a predictor of N0 disease in
patients with an adenocarcinoma. BACs typified by a lepi-
dic growth pattern along the alveoli without invasive areas
have an inactive performance and are usually expressed as
GGO or tumor shadow disappearance areas on CT. Conse-
quently, the CT characteristics (ie, GGO and TDR) of the
tumors must be identified. Notably, the features of these
different entities need to be well defined and correlated with
preoperative imaging findings and clinical outcomes. Un-
derstanding the biologic performance of these small lung
cancers preoperatively could also provide clues in selecting
patients for limited pulmonary resection. Therefore, we
examined the aggressiveness of small-sized pulmonary ad-
enocarcinomas according to the proportion of BAC increase
and correlated the proportion of GGO and TDR calculated
on the preoperative HRCT with that of BAC components
defined on sections of surgical specimens postoperatively.
The results of this study can improve our approach to
diagnosing and treating small lung adenocarcinomas, which
may become an ever more vital portion of thoracic surgical
tradition.
Patients and Methods
From January 2000 to December 2002, 424 consecutive patients
underwent operation for primary lung cancer with the same sur-
gical team. Of these patients, 114 with a pathologically proven
adenocarcinoma 3 cm or less in diameter underwent complete
removal of the primary tumor together with ipsilateral hilar and
mediastinal lymph nodes. Surgical-pathologic staging was per-
formed according to the New International Staging System for
Lung Cancer.16 This retrospective chart review at our institution
was considered exempt research.
Contrast-enhanced HRCT was performed on an Asteion
(Toshiba Medical Systems, Tokyo, Japan). All slices with 6-mm
spacing were obtained from the apex of the lung to the base. In
addition, slices with 2-mm spacing were taken through the nodule.
The images were photographed using a window level of 600
Hounsfield units (HU) with a window width of 1700 HU (lung
windows) and a level of 25 HU with a width of 350 HU (medi-
astinal windows). All lesions were completely resected within 1
month after CT. TDR and GGO were assessed by independent
observers, and discrepancies in evaluation among the observers
were resolved by averaging the values determined by them. The
observers quantified the maximum dimension of the tumor (maxD)
and the largest dimension perpendicular to the maximum axis
(perD) on both the lung and mediastinal windows. As previously
reported,15 TDR was defined as follows:
TDR (%) 1maxD perD on mediastinal windows
maxD perD on lung windows 100
The tumors resected surgically were fixed in 10% formalin and
embedded in paraffin. The sections including the largest cut were
stained with hematoxylin-eosin and elastica van Gieson, and ex-
amined histopathologically. Patients were classified into three
groups according to the proportion of BAC area relative to the
whole tumor, namely, tumors in which the BAC proportion com-
prised 0% to 20%, 21% to 50%, or 51% to 100%. These estima-
tions were performed by independent pathologists in the same
manner as that for CT reviews. The cutoffs of BAC proportion
were chosen so that an approximately equal number of patients
whose tumors had a low, medium, or high proportion of BAC
component were included in each group.
The clinical records of all patients were reviewed for age, sex,
pathologic stage, tumor size (T factor), lymph node status (N
factor), pleural involvement (P factor), lymphatic invasion (Ly
factor), and vascular invasion (V factor). P factors were defined as
follows: P0, visceral pleura is not involved by tumor; Pl, tumor has
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reached but not invaded the visceral pleura; P2, tumor has invaded
the visceral pleura but does not involve the parietal pleura; and P3,
tumor has invaded the parietal pleura or the chest wall. In the case
of lymphatic and vascular invasion, adenocarcinoma cells were
identifiable in the lymphatic and blood vessel lumen, respectively.
The Kruskal-Wallis rank test was performed to investigate the
associations between the proportion of BAC component and clin-
icopathologic factors. We also examined which TDR or GGO ratio
correlated more closely with the BAC ratio using a correlation
coefficient. To further elucidate the independent variables in rela-
tion to the prediction of nodal involvement, we performed multiple
logistic regression analyses as multivariate models in which we
used categories for sex and continuous variables for age, tumor
size, BAC ratio, GGO ratio, and TDR.
Results
The clinicopathologic findings of the patients are summa-
rized in Table 1. Of 114 patients, 52 (46%) were men and 62
were women. The mean age was 64 years (range 39-81
years). The pathologic examination showed stage I disease
in 92 patients (81%), stage II in 8 patients, stage III in 12
patients, and stage IV in 2 patients. The two patients with
stage IV disease had pulmonary metastases in the other lobe
and brain metastasis. T1 and P0 tumors were found in 91
patients (80%) and 75 patients (66%), respectively. Ninety-
eight patients (86%) had no nodal involvement, whereas
hilar and mediastinal lymph node involvement was discov-
ered in 8 patients (7%). Lymphatic and vascular invasion
occurred in 27 patients (24%) and 24 patients (21%), re-
spectively.
A total of 114 patients were divided into 3 groups in
relation to the proportion of BAC component: 0% to 20% (n
 40), 21% to 50% (n  38), and 51% to 100% (n  36).
Table 1 also shows the background factors and pathologic
findings of these groups. Although patient distribution by
age did not differ (P  .2927), there were significant dif-
ferences among the groups with respect to sex (P  .0001),
pathologic stage (P .0011), T factor (P .0035), N factor
(P  .0377), P factor (P  .0003), Ly factor (P  .0015),
and V factor (P  .0002). Male gender, advanced patho-
logic stage, larger tumor size, nodal involvement, pleural
invasion, lymphatic invasion, and vascular invasion were
TABLE 1. Clinicopathologic characteristics of patients with lung adenocarcinoma 3 cm or less in diameter in relation to
proportion of pathologic BAC
Factors Overall
Pathologic BAC
P value0%-20% 21%-50% 51%-100%
No. of patients 114 40 38 36
Age, y (mean, range) 64 (39-81) 65 (48-80) 62 (39-81) 64 (40-81) .2927
Sex
Male 52 28 18 6 .0001
Female 62 12 20 30
Pathologic stage
I 92 26 31 35 .0011
II 8 3 4 1
III 12 9 3 0
IV 2 2 0 0
T factor
T1 91 27 29 35 .0035
T2 13 5 7 1
T3 3 3 0 0
T4 7 5 2 0
N factor
N0 98 31 32 35 .0377
N1 8 3 4 1
N2 8 6 2 0
P factor
P0 75 19 24 32 .0003
P1 25 12 9 4
P2 10 5 5 0
P3 4 4 0 0
Ly factor
Ly () 87 25 27 35 .0015
Ly () 27 15 11 1
V factor
V () 90 24 30 36 .0002
V () 24 16 8 0
BAC, Bronchioloalveolar carcinoma.
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observed more frequently among patients with a smaller
proportion of BAC.
Next, to determine the independent predictors for patho-
logic nodal status, we performed a multivariate analysis.
The tumor size was significant in all multivariable models,
but age and gender were not significant in any model (Table
2). TDR (R2 0.231, P .0145) and BAC components (R2
 0.236, P .0150) were found to be more clinically useful
predictors of pN0 disease than GGO ratio (R2  0.190),
because their determination coefficients and levels of sig-
nificance were high. A marginal but not significant correla-
tion was found between GGO ratio and nodal status (P 
.0857).
We performed logistic regression analyses to investigate
which radiographic parameter correlated better with a
pathologic BAC percentage: TDR or GGO ratio (Figure 1).
A positive and significant correlation was found between
pathologic BAC versus TDR (R2  0.727, P  .0001) and
GGO ratios (R2  0.488, P  .0001). These data demon-
strated that both TDR and GGO ratios obtained preopera-
tively from CT were well associated with BAC ratios ob-
tained postoperatively from sections of the specimen and
that TDR had a stronger impact as a predictor of pathologic
BAC.
Discussion
The recent technologic improvement and extensive use of
CT scanning for mass screening allow us to choose among
various surgical options to treat small-sized lung cancers,
especially adenocarcinomas. We have had great doubts
about whether lobectomy, generally accepted as the stan-
dard cure for primary lung cancer, is compulsory for man-
aging these small lesions.17 There are, however, no accurate
preoperative indicators of the biologic behavior of a tumor
except for tumor size, location, and histology. Choosing
lesser pulmonary resections instead of standard lobectomies
requires better preoperative methods to distinguish ad-
vanced, aggressive cancers from early, indolent cancers.
Patient selection is not easy because lymph node metastases
are not exceptional in patients with small peripheral adeno-
carcinomas. Our data showed that among 114 patients with
an adenocarcinoma 3 cm or smaller in diameter, 16 (14%)
had nodal metastases and 22 (19%) had advanced-stage
diseases. The remainder had a tumor that was not biologi-
cally aggressive.
Investigators have demonstrated that the degree of BAC
component may reflect clinicopathologic and prognostic
TABLE 2. Multivariate analysis of clinicopathologic fac-
tors for positive predictive values of pathologic nodal
status
Factors Odds ratio 95% CI P value
Model 1 (R2  0.236)
Age 0.998 0.934-1.066 .9424
Sex 2.027 0.585-7.020 .2648
Size 1.205 1.063-1.366 .0036
Pathologic BAC 0.959 0.927-0.992 .0150
Model 2 (R2  0.190)
Age 0.999 0.938-1.065 .9847
Sex 1.503 0.466-4.843 .4948
Size 1.195 1.065-1.340 .0024
GGO on CT 0.960 0.916-1.006 .0857
Model 3 (R2  0.231)
Age 0.993 0.929-1.061 .8267
Sex 1.637 0.493-5.438 .4213
Size 1.200 1.061-1.357 .0037
TDR 0.963 0.935-0.993 .0145
CI, Confidence interval; R2, determination coefficient; BAC, bronchioloal-
veolar carcinoma; GGO, ground-glass opacity; TDR, tumor disappearance
rate.
Figure 1. Regression parameters of radiographic findings and
pathologic results. A, Correlation of radiographic GGO ratio and
pathologic BAC ratio (R2  0.488, P < .0001). B, Correlation of
radiographic TDR ratio and pathologic BAC ratio (R2  0.727, P <
.0001). BAC, Bronchioloalveolar carcinoma; CT, computed tomog-
raphy, GGO, ground-glass opacity; TDR, tumor shadow disappear-
ance rate.
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characteristics in patients with a small adenocarcinoma.11,12
In the present study, lung adenocarcinomas accompanied by
a higher BAC component showed a more indolent biologic
behavior, and the proportion of BAC component on sections
of surgical specimens was a significant independent predic-
tor for nodal status. However, because the BAC area can
only be defined after surgery, CT characteristics are
watched with keen interest to choose surgical approaches
preoperatively.
The proportion of GGO on HRCT was associated with
the tumor biology and subsequently with the risk for nodal
metastases and survival.8-10,18 Matsuguma and colleagues10
reported that all the cancers 2 cm or less in which the
proportion of GGO was 50% or greater were BACs without
nodal involvement and did not recur after resection. In
addition, Takamochi and associates15 proposed TDR as a
predictor of the nodal status in patients with lung adenocar-
cinomas. In general, characterizing and quantifying CT
findings used to be relatively subjective and based on visual
estimation by individuals, possibly resulting in much dis-
crepancy among the observers. Certainly, the lesions and
parts indicating GGO or TDR on CT are not always
BAC.9,19 Therefore, we analyzed the correlation between
the pathologic BAC ratio versus radiographic TDR or GGO
ratio in small-sized adenocarcinomas 3 cm or less in diam-
eter, which was one of the most crucial analyses in this
study. The extent of both TDR and GGO area correlated
well with that of BAC growth of adenocarcinomas. It must
be emphasized that TDR, rather than GGO ratio, had an
even more positive correlation with BAC proportion. In a
multivariable analysis, TDR was considered an informative
predictor of pathologic nodal status independent of age, sex,
and tumor size. These findings can become an essential
factor in planning proper management, in particular less
invasive surgery for patients with a small adenocarcinoma.
Although there were few patients in whom the BAC pro-
portion was overestimated as TDR, BAC proportion was
underestimated as TDR in some cases. The underestimation
may have occurred because tumor cells induced mucous
change at the alveoli and inflammatory cells infiltrated the
alveolar lumens. Because patients with lower TDR are not
often chosen for a lesser resection, the underestimation
could be bypassed in the actual process of surgical inter-
vention.
TDR is a reliable indicator of BAC and can serve to
predict the biologic behavior of the tumor. This may be
useful in identifying patients for lesser pulmonary resec-
tions.
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